The overarching goal of this competitive renewal application is to examine the pleiotropic effects of arteriosclerosis (AS), on brain structure and function, either alone or in combination with Alzheimer disease (AD). We propose a prospective, longitudinal study of a convenience sample (231 current + 276 new = 507 subjects), selected using the Framingham cardiovascular risk profile (FCRP) to ensure representation of subjects ranging from little to severe arteriosclerosis (AS). The PPG includes 4 Cores (Administrative, Clinical, Imaging, and Pathology) and 4 Projects. Project 1 (Reed & Jagust) will use amyloid imaging (Pittsburgh Imaging B [PIB] compound) to identify in vivo a cohort of subjects representing the full spectrum of AS, with minimal AD pathology. Project 2 (Weiner, DeCarli, and Singh) will determine the extent to which arteriosclerosis (AS) is associated with changes of brain perfusion and volume and integrity of gray matter (GM) and white matter (WM) and the extent to which these associations relate to AD- vs. CVD-pathology. .Project 6 (Zarow & Vinters) seeks to improve the clinical diagnosis of hippocampal sclerosis and to clarify its pathogenesis. Project 7 (Chui & Mungas) will test the overarching hypothesis using data obtained in the Clinical, Imaging, and Pathology Cores. The PPG has the following major specific aims: ? ? 1. To clarify associations between AS and AD, by determining the relationship between AS and amyloid imaging, using the Pittsburgh Imaging B compound (PIB). ? 2. To improve the diagnosis of vascular cognitive impairment, by characterizing the cross-sectional and longitudinal behavioral, structural and functional phenotype of persons who are PIB negative ? 3. To clarify the pathogenic significance of decreased cerebral perfusion by correlating MR perfusion with longitudinal changes in cortical gray matter and white matter ? 4. To improve our understanding of brain behavior relationships, by correlating executive and memory function with anatomically-defined changes in white matter fractional anisotropy, perfusion and GM. ? 5. To clarify the pathogenesis of hippocampal sclerosis, by comparing immuno-labelling of proteins associated with ischemic and degenerative pathways. ? 6. To improve the clinical diagnosis of hippocampal sclerosis, based on cross-sectional and longitudinal analyses of risk factors, cognitive performance, MRI. ? 7. To model the magnitude of direct and diffuse effects of AS on the brain, apart from stroke and AD. ? 8. To explore whether diffuse brain effects of AS are mediated by decreased perfusion, inflammatory or other metabolic abnormalities. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
2P01AG012435-14
Application #
7436460
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4 (J2))
Program Officer
Buckholtz, Neil
Project Start
1997-09-15
Project End
2013-05-31
Budget Start
2008-07-15
Budget End
2009-05-31
Support Year
14
Fiscal Year
2008
Total Cost
$1,953,472
Indirect Cost
Name
University of Southern California
Department
Neurology
Type
Schools of Medicine
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
La Joie, Renaud; Ayakta, Nagehan; Seeley, William W et al. (2018) Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology. Alzheimers Dement :
Lao, Yi; Nguyen, Binh; Tsao, Sinchai et al. (2017) A T1 and DTI fused 3D corpus callosum analysis in MCI subjects with high and low cardiovascular risk profile. Neuroimage Clin 14:298-307
Ramirez-Gomez, Liliana; Zheng, Ling; Reed, Bruce et al. (2017) Neuropsychological Profiles Differentiate Alzheimer Disease from Subcortical Ischemic Vascular Dementia in an Autopsy-Defined Cohort. Dement Geriatr Cogn Disord 44:1-11
Seo, Sang Won; Ayakta, Nagehan; Grinberg, Lea T et al. (2017) Regional correlations between [11C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort. Neuroimage Clin 13:130-137
Zheng, Ling; Vinters, Harry V; Mack, Wendy J et al. (2016) Differential effects of ischemic vascular disease and Alzheimer's disease on brain atrophy and cognition. J Cereb Blood Flow Metab 36:204-15
Durazzo, Timothy C; Korecka, Magdalena; Trojanowski, John Q et al. (2016) Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers. J Alzheimers Dis 54:99-107
Villeneuve, Sylvia; Rabinovici, Gil D; Cohn-Sheehy, Brendan I et al. (2015) Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain 138:2020-33
Bron, Esther E; Smits, Marion; van der Flier, Wiesje M et al. (2015) Standardized evaluation of algorithms for computer-aided diagnosis of dementia based on structural MRI: the CADDementia challenge. Neuroimage 111:562-79
Vinters, Harry V (2015) Emerging concepts in Alzheimer's disease. Annu Rev Pathol 10:291-319

Showing the most recent 10 out of 208 publications